Therefore, hepatic TM4SF5 might be involved in the earlier stages of NASH feature development via HFD1w, including enhanced blood lipid, inflammation, and SREBP1/FASN levels caused by abnormal daytime food intake and apelin expression. Here, APLN is linked to metabolic dysfunction-associated steatohepatitis.